BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 930936)

  • 1. Effect of refrigeration on bactericidal activity of four preserved multiple-dose injectable drug products.
    Lehmann CR
    Am J Hosp Pharm; 1977 Nov; 34(11):1196-1200. PubMed ID: 930936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of time, temperature, and preservative on bacterial growth in enteral nutrient solutions.
    Fagerman KE; Paauw JD; McCamish MA; Dean RE
    Am J Hosp Pharm; 1984 Jun; 41(6):1122-6. PubMed ID: 6430069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sterility and use patterns of multiple-dose vials.
    Bawden JC; Jacobson JA; Jackson JC; Anderson RK; Burke JP
    Am J Hosp Pharm; 1982 Feb; 39(2):294-7. PubMed ID: 6800255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atropine availability as an antidote for nerve agent casualties: validated rapid reformulation of high-concentration atropine from bulk powder.
    Geller RJ; Lopez GP; Cutler S; Lin D; Bachman GF; Gorman SE
    Ann Emerg Med; 2003 Apr; 41(4):453-6. PubMed ID: 12658242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outbreak of joint and soft-tissue infections associated with injections from a multiple-dose medication vial.
    Kirschke DL; Jones TF; Stratton CW; Barnett JA; Schaffner W
    Clin Infect Dis; 2003 Jun; 36(11):1369-73. PubMed ID: 12766830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the evaluation of preservative efficacy--II. The determination of antimicrobial characteristics of benzylalcohol.
    Karabit MS; Juneskans OT; Lundgren P
    J Clin Hosp Pharm; 1986 Aug; 11(4):281-9. PubMed ID: 3531242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacterial contamination of multiple-dose vials: a prevalence study.
    Mattner F; Gastmeier P
    Am J Infect Control; 2004 Feb; 32(1):12-6. PubMed ID: 14755229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability of doripenem in vitro in representative infusion solutions and infusion bags.
    Psathas PA; Kuzmission A; Ikeda K; Yasuo S
    Clin Ther; 2008 Nov; 30(11):2075-87. PubMed ID: 19108795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth of four microorganisms in polyethylene glycol-electrolyte lavage solution.
    Akly TS; DiPiro JT; Steele JC; Kemp GA
    Am J Hosp Pharm; 1986 Dec; 43(12):3013-6. PubMed ID: 3544827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calfactant sterility in multiple doses from single-use vials.
    Reiter PD; Sims C; Harmes L; Paisley J; Rosenberg AA; Valuck RJ
    Ann Pharmacother; 2003 Sep; 37(9):1219-23. PubMed ID: 12921502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival of contaminating bacteria in over-the-counter artificial tears.
    Harris MG; Gee A; Kusumoto R; Lee H
    J Am Optom Assoc; 1996 Nov; 67(11):676-80. PubMed ID: 8979661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sterility assessment of multiple use botulinum A exotoxin vials: a prospective simulation.
    Alam M; Yoo SS; Wrone DA; White LE; Kim JY
    J Am Acad Dermatol; 2006 Aug; 55(2):272-5. PubMed ID: 16844511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Room temperature stability of drug products labeled for refrigerated storage.
    Wolfert RR; Cox RM
    Am J Hosp Pharm; 1975 Jun; 32(6):585-7. PubMed ID: 1155470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of preservatives on the survival of Staphylococcus aureus and Pseudomonas aeruginosa in eyedrops containing antibiotics].
    Olszewski Z; Michalewska J; Krutul H; Scimborska L
    Acta Pol Pharm; 1976; 33(5):643-51. PubMed ID: 826120
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of the preserving efficacy of lubricant eye drops with a novel preservative system.
    Rosenthal RA; Buck SL; Henry CL; Schlech BA
    J Ocul Pharmacol Ther; 2006 Dec; 22(6):440-8. PubMed ID: 17238811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Low-level challenge test for the examination of the microbiological susceptibility, during the period of use, of liquid and semi-solid dosage forms in multiple-dose containers (author's transl)].
    Urban S; Hecker W; Schiller I
    Zentralbl Bakteriol Mikrobiol Hyg B; 1981; 172(6):478-84. PubMed ID: 7257652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Final amended report on the safety assessment of Methylparaben, Ethylparaben, Propylparaben, Isopropylparaben, Butylparaben, Isobutylparaben, and Benzylparaben as used in cosmetic products.
    Int J Toxicol; 2008; 27 Suppl 4():1-82. PubMed ID: 19101832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Final report of the safety assessment of Alcohol Denat., including SD Alcohol 3-A, SD Alcohol 30, SD Alcohol 39, SD Alcohol 39-B, SD Alcohol 39-C, SD Alcohol 40, SD Alcohol 40-B, and SD Alcohol 40-C, and the denaturants, Quassin, Brucine Sulfate/Brucine, and Denatonium Benzoate.
    Cosmetic Ingredient Review Expert Panel
    Int J Toxicol; 2008; 27 Suppl 1():1-43. PubMed ID: 18569160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contamination versus preservation of cosmetics: a review on legislation, usage, infections, and contact allergy.
    Lundov MD; Moesby L; Zachariae C; Johansen JD
    Contact Dermatitis; 2009 Feb; 60(2):70-8. PubMed ID: 19207376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative analysis of preservatives drug preparations by microbiological assay.
    Greenberg L; Naubert J
    Bull World Health Organ; 1970; 43(5):663-8. PubMed ID: 4925827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.